Characterization of two blood-brain barrier mimicking cell lines: Distribution of lectin-binding sites and perspectives for drug delivery

International Journal of Pharmaceutics

Volumn 387, Issue 1-2, 2010, Pages 34-41

  Plattner, V E ^a   Germann, B ^a   Neuhaus, W ^b   Noe, C R ^a   Gabor, F ^a   Wirth, M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b PharmaCon GmbH   (Austria)

Author keywords

Blood brain barrier; Drug targeting; ECV304; Lectins; PBMEC C1 2

Indexed keywords

DOLICHUS BIFLORUS AGGLUTININ; LENS CULINARIS AGGLUTININ; PEANUT AGGLUTININ; PLANT LECTIN; SOLANUM TUBEROSUM LECTIN; ULEX EUROPAEUS AGGLUTININ; UNCLASSIFIED DRUG; WHEAT GERM AGGLUTININ;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BLOOD BRAIN BARRIER; BRAIN CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL FATE; CELL INTERACTION; CELL SURFACE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG DISTRIBUTION; DRUG TARGETING; DRUG UPTAKE; ENDOTHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE; FLUOROMETRY; GLYCOSYLATION; HUMAN; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; SWINE;

ANIMALS; BINDING SITES; BLOOD-BRAIN BARRIER; BRAIN; CELL LINE; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; FLOW CYTOMETRY; FLUOROMETRY; HUMANS; MODELS, BIOLOGICAL; PLANT LECTINS; RATS; SWINE; TEMPERATURE; WHEAT GERM AGGLUTININS;

EID: 77649178520     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.11.030     Document Type: Article

References (41)

1. Akama T.O., Nakagawa H., Wong N.K., Sutton-Smith M., Dell A., Morris H.R., Nakayama J., Nishimura S.I., Pai A., Moremen K.W., Marth J.D., Fukuda M.N. Essential and mutually compensatory roles of α-mannosidase II and α-mannosidase IIx in N-glycan processing in vivo in mice. PNAS 2006, 103:8983-8988.
2. Benda P., Lightbody J., Sato G., Levine L., Sweet W. Differential rat glial cell strain in tissue culture. Science 1968, 161:370-371.
3. Bies C., Lehr C.M., Woodley J.F. Lectin-mediated drug targeting: history and applications. Adv. Drug. Del. Rev. 2004, 56:425-435.
4. Brown J., Reading S.J., Jones S., Fitchett C.J., Howl J., Martin A., Longland C.L., Michelangeli F., Dubrova Y.E., Brown C.A. Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab. Invest. 2000, 80:37-45.
5. Cucullo L., Aumayr B., Rapp E., Janigro D. Drug delivery and in vitro models of the blood-brain barrier. Curr. Opin. Drug. Discov. Dev. 2005, 8:89-99.
6. Dolman D.E.M., Anderson P., Rollison C., Abbott N.J. Characterisation of a new in vitro model of the blood-brain barrier (BBB). J. Physiol. 1998, 505:56-57.
7. Drexler H.G., Quentmeier H., Dirks W.G., MacLeod R.A. Bladder carcinoma cell line ECV304 is not a model system for endothelial cells. In Vitro Cell. Dev. Biol. Anim. 2002, 38:185-186.
8. Easton A.S., Abbott N.J. Bradykinin increases permeability by calcium and 5-lipoxygenase in ECV304/C6 cell culture model of the blood-brain barrier. Brain Res. 2002, 953:157-169.
9. Fatehi M.I., Gerhart D.Z., Myers T.G., Drewes L.R. Characterization of the blood-brain barrier: glycoconjugate receptors of 14 lectins in canine brain, cultured endothelial cells, and blotted membrane proteins. Brain Res. 1987, 415:30-39.
10. Fischer D, Kissel T. Histochemical characterization of primary capillary endothelial cells from porcine brains using monoclonal antibodies and fluorescein isothiocyanate-labelled lectins: implications for drug delivery. Eur. J. Pharm. Biopharm. 2001, 52:1-11.
11. Gabor F., Wirth M. Lectin-mediated drug delivery: fundamentals and perspectives. STP Pharma Sci. 2003, 13:3-16.
12. Gabor F., Stangl M., Wirth M. Lectin-mediated bioadhesion: binding characteristics of plant lectins on the enterocyte-like cell lines, Caco-2, HT-29 and HCT-8. J. Control. Rel. 1998, 55:131-142.
13. Gabor F., Klausegger U., Wirth M. The interaction between wheat germ agglutinin and other plant lectins with prostate cancer cells Du-145. Int. J. Pharm. 2001, 221:35-47.
14. Galvan M., Murali-Krishna K., Ming L.L., Baum L., Ahmed R. Alterations in cell surface carbohydrates on T cells from virally infected mice can distinguish effector/memory CD8+ T cells from naïve cells. J. Immunol. 1998, 161:641-648.
15. Garberg P., Ball M., Borg N., Cecchelli R., Fenart L., Hurst R.D., Lindmark T., Mabondzo A., Nilsson J.E., Raub T.J., Stanimirovic D., Terasaki T., Oberg J.O., Osterberg T. In vitro models for the blood-brain barrier. Toxicol. In Vitro 2005, 19:299-334.
16. Hurst R.D., Fritz I.B. Properties of an immortalized vascular endothelial/glioma cell co-culture model of the blood-brain barrier. J. Cell. Physiol. 1996, 167:81-88.
17. Janzer R.C., Raff M.C. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987, 325:253-257.
18. Joo F. Endothelial cells of the brain and other organ systems: some similarities and differences. Prog. Neurobiol. 1996, 48:255-273.
19. Kiessling F., Kartenbeck J., Haller C. Cell-cell contacts in the human cell line ECV304 exhibit both endothelial and epithelial characteristics. Cell Tissue Res. 1999, 297:131-140.
20. Krämer S.D., Schütz Y.B., Wunderli-Allenspach H., Abbott N.J., Begley D.J. Lipids in blood-brain barrier models in vitro II: Influence of glial cells on lipid classes and lipid fatty acids. In Vitro Cell. Dev. Biol. Anim. 2002, 38:566-571.
21. Kuchler-Bopp S., Delaunoy J.P., Artault J.C., Zaepfel M., Dietrich J.B. Astrocytes induce several blood-brain barrier properties in non-neural endothelial cell. Neuroreport 1999, 10:1347-1353.
22. Kuhlmann C.R., Gerigk M., Bender B., Closhen D., Lessmann V., Luhmann H.J. Fluvastatin prevents glutamate-induced blood-brain-barrier disruption in vitro. Life Sci. 2008, 82:1281-1287.
23. Kuhlmann C.R., Zehendner C.M., Gerigk M., Closhen D., Bender B., Friedl P., Luhmann H.J. MK801 blocks hypoxic blood-brain-barrier disruption and leukocyte adhesion. Neurosci. Lett. 2009, 449:168-172.
24. Lehr C.M. Lectin-mediated drug delivery: the second generation of bioadhesives. J. Control. Release 2000, 65:19-29.
25. Naeem A., Saleemuddin M., Khan R.H. Glycoprotein targeting and other applications of lectins in biotechnology. Curr. Prot. Pept. Sci. 2007, 8:261-271.
26. Neuhaus W., Plattner V.E., Wirth M., Germann B., Lachmann B., Gabor F., Noe C.R. Validation of in vitro cell culture models of the blood-brain barrier: tightness characterization of two promising cell lines. J. Pharm. Sci. 2008, 97:5158-5175.
27. Neuhaus W., Wirth M., Plattner V.E., Germann B., Gabor F., Noe C.R. Expression of Claudin-1, Claudin-3 and Claudin-5 in human blood-brain barrier mimicking cell line ECV304 is inducible by glioma-conditioned media. Neurosci. Lett. 2008, 446:59-64.
28. A-receptor modulator and its derivatives derived from Valeriana officinalis L. s.l. across an in vitro cell culture model of the blood-brain barrier. Planta Med. 2008, 74:1338-1344.
29. Nico B., Quondamatteo F., Ribatti D., Bertossi M., Russo G., Herken R., Roncali L. Ultrastructural localization of lectin binding sites in the developing brain microvasculature. Anat. Embryol. 1998, 197:305-315.
30. Nishida S., Akai F., Hiruma S., Maeda M., Tanji K., Hashimoto S. Experimental study of WGA binding on the endothelial cell surface in cerebral ischemia. Histol. Histopathol. 1986, 1:69-74.
31. Plendl J., Neumuller C., Vollmar A., Auerbach R., Sinowatz F. Isolation and characterization of endothelial cells from different organs of fetal pigs. Anat. Embryol. 1996, 194:445-456.
32. Suda K., Rothen-Rutishauser B., Günthert M., Wunderli-Allenspach H. Phenotypic characterization of human umbivilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features. In Vitro Cell. Dev. Biol. Anim. 2001, 37:505-514.
33. Szumanska G., Albrecht J. Lectin histochemistry of the rat brain following thioacetamide-induced hepatic failure. Mol. Chem. Neuropathol. 1997, 32:163-177.
34. Takahashi K., Sawasaki Y., Hata J.J., Mukai K., Goto T. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell. Dev. Biol. 1990, 25:265-274.
35. Teifel M., Friedl P. Establishment of the permanent microvascular endothelial cell line PBMEC/C1-2 from porcine brains. Exp. Cell. Res. 1996, 228:50-57.
36. Toegel S., Harrer N., Plattner V.E., Unger F.M., Viernstein H., Goldring M.B., Gabor F., Wirth M. Lectin binding studies on C-28/I2 and T/C-28a2 chondrocytes provide a basis for new tissue engineering and drug delivery perspectives in cartilage research. J. Control. Rel. 2007, 117:121-129.
37. Vanier G., Segura M., Friedl P., Lacouture S., Gottschalk M. Invasion of porcine brain microvascular endothelial cells by Streptococcus suis serotype 2. Infect. Immun. 2004, 72:1441-1449.
38. Vanier G., Szczotka A., Friedl P., Lacouture S., Jacques M., Gottschalk M. Haemophilus parasuis invades porcine brain microvascular endothelial cells. Microbiology 2006, 152:135-142.
39. Vorbrodt A.W., Lossinsky A.S., Dobrogowska D.H., Wisniewski H.M. Distribution of anionic sites and glycoconjugates on the endothelial surfaces of the developing blood-brain barrier. Brain Res. 1986, 29:69-79.
40. Wirth M., Kneuer C., Lehr C.M., Gabor F. Studying cellular binding and uptake of bioadhesive lectins. Cell Culture Models of Biological Barriers 2002, 62-93. Taylor and Francis, London/New York. C.M. Lehr (Ed.).
41. Yamamoto K., Tsuji T., Matsumoto I., Osawa T. Structural requirements for the binding of oligosaccharides and glycopeptides to immobilized wheat germ agglutinin. Biochemistry 1981, 20:5894-5899.